Asthma models

Circle Oncodesign Services

Preclinical CRO Services for Asthma diseases


Developing treatments for asthma diseases involves the use of various models to study the underlying mechanisms and test potential therapeutic interventions.

Oncodesign Services offers access to several standard preclinical models addressing a variety of lung pathologies, including asthma, and provides CRO support for de novo development of new inflammation models recently described in literature.


Get in touch

Typical readouts for Lung inflammation

Body weight

Lung weight

Clinical score


Antibody Production (specific IgG, IgE)

Mucus production

Lung histology

Gene expression

Ex vivo lung function, including compliance and elasticity (FlexiVent, SCIREQ)

Broncho-alveolar fluid (BALF) cell count and cytokine secretion

CT scan

Biomarker / drug monitoring

Oncodesign Services offers asthma models for your preclinical programs


Oncodesign Services, a CRO specialized in Inflammatory Diseases Research, helps you to choose the best models to recapitulate the features of human asthma disease and consider the ethical implications associated with animal research.

Our in vivo models bank includes:

  • Allergic asthma model in mice, induced by House Dust Mice (HDM)
  • Asthma exacerbation model in mice, induced by RSV + HDM combination
  • (In development) Corticoid-resistant asthma in mice, induced by Ovalbumin (OVA) + Influenzae


Combining different models and approaches enhances the translational relevance and robustness of preclinical research in asthma drug development.


Contact us for more detail about these models

Case study : House dust-mite (HDM)-induced allergic asthma model


HDM is one of the most important sources of indoor allergens and a significant factor underlying allergic rhinitis and allergic asthma.  HDM intranasal challenge can be used in BALB/c mice to reproduce many key features of clinical asthma:

  • HDM challenge (IN) administered 5 days per week during 3 weeks
  • Elevated levels of IgE
  • Airway inflammation
  • Goblet cell hyperplasia with mucus overproduction
  • Release of inflammatory mediators and cytokines primarily associated with Th2-type inflammation
  • Responsive to fluticasone (inhaled corticoid)

Results show allergic signature in bronchoalveolar lavage fluid (BALF) with eosinophilia in BALF & cytokine secretion, and in plasma with IgE levels.


Asthma models | Oncodesign Services


Allergic signature inbronchoalveolar lavage (BAL) and in plasma :

  • BAL cell content & cytokine secretion
  • Plasma IgE levels

Also to discover